Berger ML: Papers in reviewed journals (down to 1995)
61. Sterz F, Berger ML, Ruzicka G, Beisteiner R (2023) Lapses of the Heart: Frequency and Subjective Salience of Impressions Reported by Patients after Cardiac Arrest. J Clin Med 12: 1968
»
60. Dorninger F, König T, Scholze P, Berger ML, Zeitler G, Wiesinger C, Gundacker A, Pollak DD, Huck S, Just WW, Forss-Petter S, Pifl C, Berger J (2019) Disturbed neurotransmitter homeostasis in ether lipid deficiency. Hum Mol Genetics 28: 2046-61
59.Berger ML (2019) On the ‘Stickiness’ of Words. A Comparative Language Study Screening the Internet for English, German, French and Latin Phrases. J Quant. Linguist 26: 81-94
»
58. Berger ML (2016) Soaping the NMDA receptor: Various types of detergents influence differently [3H]MK-801 binding to rat brain membranes. Biochim Biophys Acta 1858: 116-122
57. Berger ML, Rebernik P (2015) Differential influence of 7 cations on 16 non- competitive NMDA receptor blockers. Bioorg Med Chem Lett 25 (19): 4131-35
56. Ramerstorfer J, Foppa V, Thiery H, Hermange P, Janody S, Berger ML, Dodd R, Sieghart W (2015) GABAA Receptor Subtype- Selectivity of Novel Bicuculline Derivates. Curr Med Chem 22: 771-780
55. Berger ML, Maciejewska D, Vanden Eynde JJ, Mottamal M, Zabinski J, Kazmierczak P, Rezler M, Jarak I, Piantanida I, Karminski-Zamola G, Mayence A, Rebernik P, Kumar A, Ismail MA, Boykin DW, Huang TL (2015) Pentamidine analogs as inhibitors of [3H]MK-801 and [3H]ifenprodil binding to rat brain NMDA receptors. Bioorg Med Chem 23 (15): 4489-4500
54. Hnat J, Berger ML (2015) Radioligand kinetics at the NMDA receptor channel revisited: an active part by Na+ and Tris. Neurotransmitter 2: e 945
53. Karabacak Y, Sase S, Aher YD, Sase A, Saroja SR, Cicvaric A, Höger H, Berger ML, Bakulev V, Sitte HH, Leban J, Monje FJ, Lubec G (2015) The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze. Front Behav Neurosci 9: 215
52. Parnia S, Spearpoint K, de Vos G, Fenwick P, Goldberg D, Yang J, Zhu J, Baker K, Killingback H, McLean P, Wood M, Zafari AM, Dickert N, Beisteiner R, Sterz F, Berger ML, Warlow C, Bullock S, Lovett S, Metcalfe-Smith R, Marti-Navarette S, Cushing P, Wills P, Harris K, Sutton J, Walmsley A, Deakin CD, Little P, Farber M, Greyson B, Schoenfeld ER (2014) AWARE - AWAREness during REsuscitation - A prospective study. Resuscitation 85: 1799-1805
»
51. Mark C, Bornatowicz B, Mitterhauser M, Hendl M, Nics L, Haeusler D, Lanzenberger R, Berger ML, Spreizer H, Wadsak W (2013) Development and automation of a novel NET-PET tracer: [11C]Me@APPI. Nucl Med and Biol 40: 295-303
50. Palangsuntikul R, Berner H, Berger ML, Wolschann P (2013) Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT-1A and 5HT-2A Receptors. Molecules 18: 8799-8811
49. Berger ML, Hammerschmidt F, Qian R, Hahner S, Schirbel A, Stichelberger M, Schibli R, Yu J, Arion VB, Woschek A, Öhler E, Zolle IM (2013) [3H]Metyrapol and 4-[131I]Iodometomidate Label Overlapping, but Not Identical, Binding Sites on Rat Adrenal Membranes. Mol Pharmaceutics 10: 1119-30
48. Berger ML, Pöhler T, Schadt O, Stanger M, Rebernik P, Scholze P, Noe CR (2012) Exploring the Polyamine Regulatory Site of the NMDA Receptor: a Parallel Synthesis Approach. ChemMedChem 8 (1): 82-94
47. Berger ML, Palangsuntikul R, Rebernik P, Wolschann P, Berner H (2012) Screening of 64 tryptamines at NMDA, 5-HT1A, and 5-HT2A receptors: a comparative binding and modeling study. Curr Med Chem 19 (18): 3044-57
46. Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C (2011) Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice. Neuroscience 180: 280-292
45. Neuhaus W, Freidl M, Szkokan P, Berger ML, Wirth M, Winkler J, Gabor F, Pifl C, Noe CR (2011) Effects of NMDA receptor modulators on a blood-brain barrier in vitro model. Brain Res 1394: 49-61
44. Berger ML, Schweifer A, Rebernik P, Hammerschmidt F (2009) NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl) piperidine enantiomers and of related compounds. Bioorg Med Chem 17: 3456-62
43. Atucha E, Hammerschmidt F, Zolle I, Sieghart W, Berger ML (2009) Structure- activity relationship of etomidate derivatives at the GABAA receptor: Comparison with binding to 11-beta-hydroxylase. Bioorg Med Chem Lett 19: 4284-4287

42. Pifl C, Wolf A, Rebernik P, Reither H, Berger ML (2009) Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner. Neuropharmacology 56: 531-540
41. Zolle IM, Berger ML, Hammerschmidt F, Hahner S, Schirbel A, Peric-Simov B (2008) New Selective Inhibitors of Steroid 11-Hydroxylation in the Adrenal Cortex. Synthesis and Structure-Activity Relationship of Potent Etomidate Analogues. J Med Chem 51: 2244-53
40. Berndt U, Stanetty C, Wanek T, Kuntner C, Stanek J, Berger ML, Bauer M, Henriksen G, Wester H-J, Kvaternik H, Angelberger P, Noe CR (2008) Synthesis of a [18F]fluorobenzothiazole as potential amyloid imaging agent. J Label Compd Radiopharm 51: 137-45
39. Pöhler T, Schadt O, Niepel D, Rebernik P, Berger ML, Noe CR (2007) New polyamine-sensitive inhibitors of the NMDA receptor: Syntheses and pharmacological evaluation. Eur J Med Chem 42: 175-197
38. Berger ML, Bitar AY, Waitner MJ, Rebernik P, O'Sullivan MC (2006) Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents. Bioorg Med Chem Lett 16: 2837-41
37. Buchstaller H-P, Siebert CD, Steinmetz R, Frank I, Berger ML, Gottschlich R, Leibrock J, Krug M, Steinhilber D,Noe CR (2006) Synthesis of thieno[2,3-b] pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the NMDA receptor. J Med Chem 49: 864-71
36. Reiterer S, Hemmelmann C, Rappelsberger P, Berger ML (2005) Characteristic functional networks in high- versus low second language speakers detected also during native language processing: An explorative EEG coherence study in 6 frequency bands. Cog Brain Res 25: 566-78
35. Reiterer S, Berger ML, Hemmelmann C, Rappelsberger, P (2005) Decreased EEG coherence between prefrontal electrodes: a correlate of high language proficiency? Exp Brain Res 163: 109-13
34. Schirbel A, Zolle I, Hammerschmidt F, Berger ML, Schiller D, Kvaternik H, Reiners C (2004) [123/131I]Iodometomidate as a radioligand for functional diagnosis of adrenal disease: synthesis, structural requirements and biodistribution. Radiochim Acta 92: 297-303

33. Berger ML, Noe CR (2003) Polyamine regulation of the NMDA receptor complex as a target in drug development. Curr Trends Med Chem 3: 51-64
32. Furtmüller R, Schlag MG, Berger ML, Hopf R, Huck S, Sieghart W, Redl H (2002) Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid-A-receptor antagonistic effect. J Pharmacol Exp Ther 301: 168-73
31.Sitte HH, Wanschitz J, Budka H, Berger ML (2001) Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis. Acta Neuropathol 101: 75-78
30. Krapfenbauer K, Berger ML, Lubec G, Fountoulakis M (2001) Changes in the brain protein levels following administration of kainic acid. Electrophoresis 22: 2086-91
29. Krapfenbauer K, Berger ML, Lubec G, Fountoulakis M (2001) Changes in the levels of low-abundance brain proteins induced by kainic acid. Eur J Biochem 268: 3532-37
28. Berger ML (2000) Tryptamine derivatives as non-competitive N-methyl- D-aspartate receptor blockers: studies using [3H]MK-801 binding in rat hippocampal membranes. Neurosci Lett 296: 29-33
27. Berger ML, Rebernik P (1999) Zinc and Ifenprodil Allosterically Inhibit Two Separate Polyamine-Sensitive Sites at N-Methyl-D-Aspartate Receptor Complex. J Pharmacol Exp Ther 289: 1584-91
26. Berger ML, Schödl C, Noe CR (1998) Inverse agonists at the polyamine- sensitive modulatory site of the NMDA receptor: 50-fold increase in potency by insertion of an aromatic ring into an alkanediamine chain. Eur J Med Chem 33: 3-14

25. Veitl M, Schweiger U, Berger ML (1997) Stochastic Simulation of Ligand- Receptor Interaction. Comput Biomed Res 30:427-450
24. Donkor IO, Berger ML (1997) Inhibitory effects of pentamidine analogues on spermine stimulated ligand binding to the NMDA receptor complex. Bioorg Med Chem Lett 7: 1455.60
23. Noe CR, Knollmüller M, Schödl C, Berger ML (1996) 2,3-Dihydro- 2-carboxy-1H-indol-3-essigsäuren als Sonden zur Untersuchung exzitatorischer Aminosäurerezeptoren. Sci. Pharm. 64: 577-590
22. Berger ML, Khomutov AR, Rebernik P (1996) Aminooxy-analogues of spermine: new partial agonists and antagonists at the polyamine site of the rat hippocampal NMDA receptor complex. Neurosci Lett 203: 25-28
21. Berger ML, Schödl C, Noe CR (1996) Benzimidazol-type Glycine Antagonists: The Role of the Ring Nitrogen Atom. Arch Pharm Pharm Med Chem 329, 121-24
20. Berger ML (1995) On the true affinity of glycine for its binding site at the NMDA receptor complex. J Pharmacol Tox Meth 34: 79-88
MLB